TETRAMED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tetramed, and what generic alternatives are available?
Tetramed is a drug marketed by Ivax Sub Teva Pharms and is included in one NDA.
The generic ingredient in TETRAMED is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tetramed
A generic version of TETRAMED was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
Summary for TETRAMED
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Patent Applications: | 4,504 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TETRAMED at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TETRAMED
US Patents and Regulatory Information for TETRAMED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ivax Sub Teva Pharms | TETRAMED | tetracycline hydrochloride | SUSPENSION;ORAL | 061468-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |